Press Release October 01, 2019

Goodwin Names 31 New Partners

Global law firm Goodwin announced today that 33 lawyers have been elected to the firm’s partnership, effective immediately.

“We are delighted to welcome these talented lawyers to the partnership, said Rob Insolia, Goodwin’s Chairman. “Their dedication to our clients, commitment to our collaborative culture, and significant leadership skills have set them apart. We look forward to their continuing contributions to our collective future.” 

The newly elected partners include:

  • Freddie Akrouche (Real Estate Industry, Boston) represents clients in commercial real estate transactions, including joint ventures; restructurings and recapitalizations; mortgage, construction and mezzanine financings; and asset-level and entity-level acquisitions and dispositions. 
  • Michael H. Brodowski (Technology & Life Sciences, Boston) advises companies, investors, and academic and research institutions on patent and other IP matters, focusing on the strategic prosecution and development of patent portfolios in the U.S. and abroad. 
  • Nikolaus J. Caro (Private Equity, New York) primarily represents private equity sponsors and their portfolio companies, public companies, investment banks, direct lenders, and other financial institutions in structuring and negotiating debt financing transactions. 
  • Ravi Chopra (Private Equity, London) specializes in structuring private capital vehicles investing across real assets, private equity, technology, and life sciences. He has particular expertise in advising on house incentivization and equity arrangements, co-investment platforms, and longer term capital. 
  • Charles-Henri de Gouvion Saint Cyr (Tax, Paris) specializes on the tax aspects of mergers and acquisitions, with a focus on real estate, leveraged buyouts and private equity transactions. He also has extensive experience in tax structuring of investment funds dedicated to private equity, real estate, debt or infrastructure as well as tax litigation. Much of his work involves advising on cross-border transactions.
  • Alexandra S. Denniston (ERISA, Boston) advises public and private companies with respect to the employee benefit and compensation aspects of M&A, initial public offerings, and other corporate transactions. 
  • Brian T. Drummond (IP Litigation, Boston) focuses on patent matters, with a concentration on pharmaceuticals and biotechnology, and participatesin all phases of patent litigation, including pre-suit investigations, fact and expert discovery, federal courttrials, and appeals to the Federal Circuit.
  • Peter G. Hanoian (Private Equity, Boston) specializes in advising private equity sponsors and their portfolio companies in domestic and cross-border transactions, including leveraged buyouts, M&A, recapitalizations, growth equity investments, joint ventures, and general corporate matters, as well as management teams and operating executives in sale transactions.
  • Courtney M. Hetrick (Technology & Life Sciences, Boston) counsels public and private companies in all stages of maturity on corporate matters including entity formation, venture capital financings, public securities offerings, M&A, and securities law compliance.
  • Kimberly Monty Holzel (Financial Industry, Boston) specializes in FinTech and consumer banking, counseling  clients on building or investing in tech-enabled financial services, such as loans, payment systems, credit cards, mobile apps, and virtual currency, in compliance with financial regulations.
  • Kathleen Kean (Technology & Life Sciences, Boston) represents private and public biotech, pharmaceutical, diagnostic, and medical device companies in connection with strategic collaborations and intellectual property licensing, commercial, and M&A transactions.
  • Abhishek Krishnan (Private Equity, Hong Kong) advises corporate and private equity clients on M&A, joint ventures, venture capital investments, exits, and restructurings in China, India, and across Asia.
  • Katie Leah (Tax, London) focuses on the tax aspects of all types of private equity work, including UK, multi-jurisdictional, and pan-European M&A, and advises on UK corporation tax, VAT, and stamp taxes as well as management packages and share incentive schemes.
  • Alexandra Kelly Lewis (Real Estate Industry, Boston) represents clients in commercial real estate transactions including joint ventures; senior, construction and mezzanine financings (for both lenders and borrowers); and asset-level and entity-level acquisitions and dispositions.
  • Andy Lock (Private Equity, Boston) specializes in advising private equity sponsors and their portfolio companies, management teams, and operating executives in M&A and other transactional matters, including leveraged buyouts, recapitalizations, growth equity investments, joint ventures, and exits, as well as general corporate matters.
  • Michael R. Miller (Private Equity, New York) represents financial sponsors and their portfolio companies in the structuring, negotiation, and implementation of corporate and transactional matters.
  • Jacob R. Osborn (Specialty Litigation, Washington, D.C.) advises clients with respect to global trade, CFIUS, export controls, sanctions, digital currency, blockchain, privacy, cybersecurity, software, and encryption matters.
  • Shih-Chi Pan (Private Equity, Hong Kong) focuses on cross border transactions for private equity firms and portfolio companies and has extensive experience in M&A, leveraged buyouts, stock and asset sales and joint ventures, and early- and late-stage venture capital and growth equity investments.
  • Adrien Paturaud (Private Equity, Paris) focuses on leveraged acquisition finance and corporate finance, representing banks, debt funds, financial sponsors,and corporate borrowers on bank and bond financings. He has also developed an expertise in equity bridge financings, representing both investment funds and banks.
  • Stephanie Philbin (Technology & Life Sciences, Washington, D.C.) provides counseling and advocacy to medical device, pharmaceutical, and biotech companies subject to regulation by the Food and Drug Administration under the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act.
  • Todd Pollock (Tax, New York) advises clients on tax issues relating to investments in partnerships and joint ventures, real estate investments, private equity fund formations and investments, REITs, M&A, general corporate transactions, and cross-border transactions. 
  • Andrew R. Pusar (Technology & Life Sciences, New York) counsels private and public companies in all stages of the corporate lifecycle on corporate matters including pre-incorporation planning, entity formation, venture capital financings, public securities offerings, M&A, and securities law reporting and compliance.
  • Brian Raynor (Private Equity, San Francisco) advises private equity sponsors and their portfolio companies in transactions including acquisitions and divestitures, leveraged buyouts, recapitalizations, minority and growth equity investments, and joint ventures.
  • Samuel Rubin (Financial Industry, New York) represents financial institutions and major corporations in securities, RICO, ERISA, antitrust,and other commercial disputes in federal and state courts and before regulatory bodies.
  • Jaime A. Santos (Specialty Litigation, Washington, D.C.) concentrates on appellate litigation, particularly in cases involving ERISA, intellectual property, product litigation, and constitutional issues. She has argued in the Fourth, Seventh, and Ninth Circuits, and drafted briefs filed in the U.S. Supreme Court and nine federal courts of appeals.
  • Martin Smith (Real Estate Industry, London) advises clients on all aspects of investment in UK real estate (including acquisition, development, and disposal) and on hotel management agreements across Europe, the Middle East, and Africa. 
  • Matthew M. Stayman (Real Estate Industry, Boston) represents real estate investment funds, REITs, and other owners and operators of commercial real estate in a variety of transactions including sales and acquisitions, joint venture formation, and construction and mortgage financings, as well as subscription-secured credit facilities.
  • Erini R. Svokos (Technology & Life Sciences, New York) represents private and public biotech, pharmaceutical, diagnostic, and medical device companies in connection with strategic collaborations and intellectual property licensing, commercial, and M&A transactions.
  • Alexandra Valenti (IP Litigation, New York) specializes in patent matters across a wide variety of industries. She represents clients in patent infringement lawsuits in federal courts nationwide, and has significant trial and appellate experience. 
  • Melissa Schwab Wright (Private Equity, Boston) advises lenders and borrowers in finance and restructuring transactions, and has extensive experience managing large, syndicated, multi-tranche financings.